StockData
Ardelyx, Inc. logo

Ardelyx, Inc. (ARDX) stock

ARDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 9/3058% below fair value
$3.18+0.11 (+3.58%)

Close on Nov 17, 2026Market cap $792.42MP/E –Yield –

Ardelyx operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Ardelyx's operating cash flow for the twelve months ending Jun 30, 2026 was -$17.32M. For fiscal 2025 it was -$42.48M. The highest annual figure on record is $21.98M in fiscal 2012.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$42.48M–
FY2024Dec 31, 2024-$44.81M–
FY2023Dec 31, 2023-$89.72M–
FY2022Dec 31, 2022-$70.04M–
FY2021Dec 31, 2021-$152.55M–
FY2020Dec 31, 2020-$81.44M–
FY2019Dec 31, 2019-$76.48M–
FY2018Dec 31, 2018-$70.27M–
FY2017Dec 31, 2017-$65.19M–
FY2016Dec 31, 2016-$92.53M–
FY2015Dec 31, 2015-$71.84M-636.2%
FY2014Dec 31, 2014$13.40M+639.8%
FY2013Dec 31, 2013$1.81M-91.8%
FY2012Dec 31, 2012$21.98M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$6.40M–
Q1 FY2026Mar 31, 2026-$32.24M–
Q4 FY2025Dec 31, 2025$20.95M+113.6%
Q3 FY2025Sep 30, 2025$365.00K-27.1%
Q2 FY2025Jun 30, 2025-$25.34M–
Q1 FY2025Mar 31, 2025-$38.46M–
Q4 FY2024Dec 31, 2024$9.81M–
Q3 FY2024Sep 30, 2024$501.00K–
Q2 FY2024Jun 30, 2024-$19.40M–
Q1 FY2024Mar 31, 2024-$35.72M–
Q4 FY2023Dec 31, 2023-$8.72M-161.0%
Q3 FY2023Sep 30, 2023-$21.47M–
Q2 FY2023Jun 30, 2023-$14.74M–
Q1 FY2023Mar 31, 2023-$44.80M–
Q4 FY2022Dec 31, 2022$14.28M–
Q3 FY2022Sep 30, 2022-$25.43M–
Q2 FY2022Jun 30, 2022-$31.28M–
Q1 FY2022Mar 31, 2022-$27.62M–
Q4 FY2021Dec 31, 2021-$39.47M–
Q3 FY2021Sep 30, 2021-$34.59M–
Q2 FY2021Jun 30, 2021-$34.28M–
Q1 FY2021Mar 31, 2021-$44.22M–
Q4 FY2020Dec 31, 2020-$17.59M–
Q3 FY2020Sep 30, 2020-$19.88M–
Q2 FY2020Jun 30, 2020-$19.02M–
Q1 FY2020Mar 31, 2020-$24.95M–
Q4 FY2019Dec 31, 2019-$11.14M–
Q3 FY2019Sep 30, 2019-$20.61M–
Q2 FY2019Jun 30, 2019-$27.82M–
Q1 FY2019Mar 31, 2019-$16.91M–
Q4 FY2018Dec 31, 2018-$18.44M-492.4%
Q3 FY2018Sep 30, 2018-$27.02M–
Q2 FY2018Jun 30, 2018-$18.02M–
Q1 FY2018Mar 31, 2018-$6.80M–
Q4 FY2017Dec 31, 2017$4.70M–
Q3 FY2017Sep 30, 2017-$19.24M–
Q2 FY2017Jun 30, 2017-$23.89M–
Q1 FY2017Mar 31, 2017-$26.76M–
Q4 FY2016Dec 31, 2016-$26.75M–
Q3 FY2016Sep 30, 2016-$24.64M–

More Ardelyx figures

See a number that looks wrong?